Materials Science Capabilities
Implementation of an established approach, using technologies to fully characterise both molecular level properties and bulk properties, can be applied either predictively, for optimisation purposes or for inclusion in regulatory documentation. These technologies can be applied during clinical development or to materials already in the market place. With respect to drug substance, close collaboration between CMC and API teams will ensure determination of the most appropriate form for pharmaceutical application, offering a long term view to successful project progression. Similarly, characterisation of excipients, or drug – excipient interactions, either throughout the recommended manufacturing process or in the final product, can be employed to ensure robust performance.
CPhI WorldwideCPhI Worldwide will be attended by Nathalie Huther, Business Development Manager Europe. Nathalie will be located at the DIT stand: 9J40
CPhI WorldwideDates: 9th - 11th OctoberLocation: Madrid, Spain
CMAC Open DayThe CMAC Open Day event will be attended by Gareth Jenkins, Chief Scientific Officer.
CMAC Open DayDates: 25th - 26th OctoberLocation: Glasgow, UK
Organic Process Research & DevelopmentThe Organic Process R&D conference will be attended by Nathalie Huther, Business Development Manager Europe.
Organic Process Research & DevelopmentDates: 29th - 31st OctoberLocation: Milan, Italy